{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:24:04Z","timestamp":1789377844803,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12035-015-9311-2","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T03:14:38Z","timestamp":1436325278000},"page":"2685-2697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Increased Spontaneous Central Bleeding and Cognition Impairment in APP\/PS1 Mice with Poorly Controlled Diabetes Mellitus"],"prefix":"10.1007","volume":"53","author":[{"given":"Juan Jos\u00e9","family":"Ramos-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Infante-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Galindo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaiza","family":"Garcia-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lechuga-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garcia-Alloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"9311_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","volume":"66","author":"S Craft","year":"2009","unstructured":"Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66:300\u2013305","journal-title":"Arch Neurol"},{"key":"9311_CR2","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9311_CR3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","volume":"39","author":"A Ott","year":"1996","unstructured":"Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1996) Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 39:1392\u20131397","journal-title":"Diabetologia"},{"key":"9311_CR4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53:1937\u20131942","journal-title":"Neurology"},{"key":"9311_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2009.09.022","volume":"288","author":"M Plastino","year":"2010","unstructured":"Plastino M, Fava A, Pirritano D et al (2010) Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288:112\u2013116","journal-title":"J Neurol Sci"},{"key":"9311_CR6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2337\/diacare.24.9.1541","volume":"24","author":"EA Northam","year":"2001","unstructured":"Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA (2001) Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24:1541\u20131546","journal-title":"Diabetes Care"},{"key":"9311_CR7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s125-002-8250-6","volume":"45","author":"EJ Schoenle","year":"2002","unstructured":"Schoenle EJ, Schoenle D, Molinari L, Largo RH (2002) Impaired intellectual development in children with type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45:108\u2013114","journal-title":"Diabetologia"},{"key":"9311_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fncel.2014.00022","volume":"8","author":"NB Khoury El","year":"2014","unstructured":"El Khoury NB, Gratuze M, Papon MA, Bretteville A, Planel E (2014) Insulin dysfunction and Tau pathology. Front Cell Neurosci 8:22","journal-title":"Front Cell Neurosci"},{"key":"9311_CR9","doi-asserted-by":"crossref","unstructured":"Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011) Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis. J Cell Mol Med 15(9): 1807\u20131821","DOI":"10.1111\/j.1582-4934.2011.01318.x"},{"key":"9311_CR10","volume-title":"Streptozotocin as a tool to induce central pathology and cognitive impairment in rodents. Streptozotocin: uses, mechanism of action and side effects","author":"M Garcia-Alloza","year":"2014","unstructured":"Garcia-Alloza M (2014) Streptozotocin as a tool to induce central pathology and cognitive impairment in rodents. Streptozotocin: uses, mechanism of action and side effects. Nova Science Publishers, Hauppauge"},{"key":"9311_CR11","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.psyneuen.2013.05.010","volume":"38","author":"JJ Ramos-Rodriguez","year":"2013","unstructured":"Ramos-Rodriguez JJ, Ortiz O, Jimenez-Palomares M et al (2013) Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology 38:2462\u20132475","journal-title":"Psychoneuroendocrinology"},{"key":"9311_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2014.06.005","volume":"48","author":"JJ Ramos-Rodriguez","year":"2014","unstructured":"Ramos-Rodriguez JJ, Ortiz-Barajas O, Gamero-Carrasco C, de la Rosa PR, Infante-Garcia C, Zopeque-Garcia N, Lechuga-Sancho AM, Garcia-Alloza M (2014) Prediabetes-induced vascular alterations exacerbate central pathology in APPswe\/PS1dE9 mice. Psychoneuroendocrinology 48:123\u2013135","journal-title":"Psychoneuroendocrinology"},{"key":"9311_CR13","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","volume":"150","author":"B Kim","year":"2009","unstructured":"Kim B, Backus C, Oh S, Hayes JM, Feldman EL (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150:5294\u20135301","journal-title":"Endocrinology"},{"key":"9311_CR14","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/db06-0485","volume":"55","author":"BJ Clodfelder-Miller","year":"2006","unstructured":"Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55:3320\u20133325","journal-title":"Diabetes"},{"key":"9311_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","volume":"10","author":"SC Correia","year":"2011","unstructured":"Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s disease? Ageing Res Rev 10:264\u2013273","journal-title":"Ageing Res Rev"},{"key":"9311_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol 18:253\u2013266","journal-title":"Brain Pathol"},{"key":"9311_CR17","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1093\/brain\/awr300","volume":"134","author":"M Garcia-Alloza","year":"2011","unstructured":"Garcia-Alloza M, Gregory J, Kuchibhotla KV et al (2011) Cerebrovascular lesions induce transient beta-amyloid deposition. Brain 134:3697\u20133707","journal-title":"Brain"},{"key":"9311_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ et al (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29\u201338","journal-title":"Arch Neurol"},{"key":"9311_CR19","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1093\/brain\/awn288","volume":"131","author":"GJ Francis","year":"2008","unstructured":"Francis GJ, Martinez JA, Liu WQ et al (2008) Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain 131:3311\u20133334","journal-title":"Brain"},{"key":"9311_CR20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX et al (2006) Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516\u2013524","journal-title":"Neurobiol Dis"},{"key":"9311_CR21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nlm.2005.07.002","volume":"84","author":"E Dere","year":"2005","unstructured":"Dere E, Huston JP, De Souza Silva MA (2005) Integrated memory for objects, places, and temporal order: evidence for episodic-like memory in mice. Neurobiol Learn Mem 84:214\u2013221","journal-title":"Neurobiol Learn Mem"},{"key":"9311_CR22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","volume":"451","author":"M Meyer-Luehmann","year":"2008","unstructured":"Meyer-Luehmann M, Spires-Jones TL, Prada C et al (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer\u2019s disease. Nature 451:720\u2013724","journal-title":"Nature"},{"key":"9311_CR23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","volume":"19","author":"Y Li","year":"2010","unstructured":"Li Y, Duffy KB, Ottinger MA et al (2010) GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer\u2019s disease. J Alzheimers Dis 19:1205\u20131219","journal-title":"J Alzheimers Dis"},{"key":"9311_CR24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00023210-200216070-00001","volume":"16","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H (2002) Hypertension and hypercholesterolaemia as risk factors for Alzheimer\u2019s disease: potential for pharmacological intervention. CNS Drugs 16:435\u2013444","journal-title":"CNS Drugs"},{"key":"9311_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","volume":"61","author":"MA Pappolla","year":"2003","unstructured":"Pappolla MA, Bryant-Thomas TK, Herbert D et al (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61:199\u2013205","journal-title":"Neurology"},{"key":"9311_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneur.64.1.93","volume":"64","author":"G Razay","year":"2007","unstructured":"Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64:93\u201396","journal-title":"Arch Neurol"},{"key":"9311_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000105927","volume":"24","author":"M Muller","year":"2007","unstructured":"Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24:185\u2013192","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9311_CR28","unstructured":"Garcia-Alloza M (2014) Streptozotocin as a tool to induce central pathology and cognitive impairment in rodents. In: Gauthier, E L (ed) Streptozotocin: uses, mechanism of action and side effects. Nova Science Publishers, Inc., Hauppauge, NY"},{"key":"9311_CR29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.psyneuen.2008.04.013","volume":"33","author":"GK Cooray","year":"2008","unstructured":"Cooray GK, Maurex L, Brismar T (2008) Cognitive impairment correlates to low auditory event-related potential amplitudes in type 1 diabetes. Psychoneuroendocrinology 33:942\u2013950","journal-title":"Psychoneuroendocrinology"},{"key":"9311_CR30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","volume":"63","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187\u20131192","journal-title":"Neurology"},{"key":"9311_CR31","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","volume":"75","author":"EM Schrijvers","year":"2010","unstructured":"Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM (2010) Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study. Neurology 75:1982\u20131987","journal-title":"Neurology"},{"key":"9311_CR32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM Monte de la","year":"2008","unstructured":"de la Monte SM, Wands JR (2008) Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2:1101\u20131113","journal-title":"J Diabetes Sci Technol"},{"key":"9311_CR33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/WAD.0b013e31820ce536","volume":"25","author":"LY Ma","year":"2011","unstructured":"Ma LY, Zhang DM, Tang Y et al (2011) Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats. Alzheimer Dis Assoc Disord 25:352\u2013363","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9311_CR34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1326-5-46","volume":"5","author":"X Wang","year":"2010","unstructured":"Wang X, Zheng W, Xie JW, Wang T, Wang SL, Teng WP, Wang ZY (2010) Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener 5:46","journal-title":"Mol Neurodegener"},{"key":"9311_CR35","doi-asserted-by":"crossref","unstructured":"Ikeda H, Ikegami M, Kai M, Kamei J (2015) Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: interaction with glutamatergic functions. Exp Neurol 269:233\u2013241","DOI":"10.1016\/j.expneurol.2015.04.012"},{"key":"9311_CR36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.09.041","volume":"744","author":"D Gupta","year":"2014","unstructured":"Gupta D, Radhakrishnan M, Kurhe Y (2014) Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system. Eur J Pharmacol 744:59\u201366","journal-title":"Eur J Pharmacol"},{"key":"9311_CR37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/diacare.29.03.06.dc05-1901","volume":"29","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA (2006) Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29:560\u2013565","journal-title":"Diabetes Care"},{"key":"9311_CR38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","volume":"29","author":"CT Kodl","year":"2008","unstructured":"Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29:494\u2013511","journal-title":"Endocr Rev"},{"key":"9311_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nbd.2011.06.005","volume":"44","author":"A Devisser","year":"2011","unstructured":"Devisser A, Yang C, Herring A et al (2011) Differential impact of diabetes and hypertension in the brain: adverse effects in grey matter. Neurobiol Dis 44:161\u2013173","journal-title":"Neurobiol Dis"},{"key":"9311_CR40","first-page":"796840","volume":"2014","author":"JQ Wang","year":"2014","unstructured":"Wang JQ, Yin J, Song YF, Zhang L, Ren YX, Wang DG, Gao LP, Jing YH (2014) Brain aging and AD-like pathology in streptozotocin-induced diabetic rats. J Diabetes Res 2014:796840","journal-title":"J Diabetes Res"},{"key":"9311_CR41","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.2337\/db14-0375","volume":"63","author":"M Vandal","year":"2014","unstructured":"Vandal M, White PJ, Tremblay C et al (2014) Insulin reverses the high-fat diet-induced increase in brain abeta and improves memory in an animal model of Alzheimer disease. Diabetes 63:4291\u20134301","journal-title":"Diabetes"},{"key":"9311_CR42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-0033-1345120","volume":"121","author":"JB Frokjaer","year":"2013","unstructured":"Frokjaer JB, Brock C, Softeland E, Dimcevski G, Gregersen H, Simren M, M Drewes A (2013) Macrostructural brain changes in patients with longstanding type 1 diabetes mellitus - a cortical thickness analysis study. Exp Clin Endocrinol Diabetes 121:354\u2013360","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9311_CR43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jdiacomp.2013.07.001","volume":"27","author":"TM Hughes","year":"2013","unstructured":"Hughes TM, Ryan CM, Aizenstein HJ et al (2013) Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J Diabetes Complicat 27:558\u2013564","journal-title":"J Diabetes Complicat"},{"key":"9311_CR44","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/db14-0348","volume":"63","author":"GJ Biessels","year":"2014","unstructured":"Biessels GJ, Reijmer YD (2014) Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63:2244\u20132252","journal-title":"Diabetes"},{"key":"9311_CR45","first-page":"607","volume":"24","author":"C Gao","year":"2013","unstructured":"Gao C, Liu Y, Li L, Holscher C (2013) New animal models of Alzheimer\u2019s disease that display insulin desensitization in the brain. Rev Neurosci 24:607\u2013615","journal-title":"Rev Neurosci"},{"key":"9311_CR46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","volume":"223","author":"CG Jolivalt","year":"2010","unstructured":"Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E (2010) Type 1 diabetes exaggerates features of Alzheimer\u2019s disease in APP transgenic mice. Exp Neurol 223:422\u2013431","journal-title":"Exp Neurol"},{"key":"9311_CR47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00207454.2013.866110","volume":"124","author":"X Wang","year":"2014","unstructured":"Wang X, Yu S, Hu JP, Wang CY, Wang Y, Liu HX, Liu YL (2014) Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs\/RAGE\/NF-kappaB pathway. Int J Neurosci 124:601\u2013608","journal-title":"Int J Neurosci"},{"key":"9311_CR48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032792","volume":"7","author":"L Devi","year":"2012","unstructured":"Devi L, Alldred MJ, Ginsberg SD, Ohno M (2012) Mechanisms underlying insulin deficiency-induced acceleration of beta-amyloidosis in a mouse model of Alzheimer\u2019s disease. PLoS One 7, e32792","journal-title":"PLoS One"},{"key":"9311_CR49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03346691","volume":"34","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu L, Lu S, Wang D, Liu X, Xie L, Wang G (2011) Impaired amyloid beta-degrading enzymes in brain of streptozotocin-induced diabetic rats. J Endocrinol Invest 34:26\u201331","journal-title":"J Endocrinol Invest"},{"key":"9311_CR50","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/acel.12002","volume":"11","author":"A Currais","year":"2012","unstructured":"Currais A, Prior M, Lo D, Jolivalt C, Schubert D, Maher P (2012) Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell 11:1017\u20131026","journal-title":"Aging Cell"},{"key":"9311_CR51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1474-4422(12)70005-4","volume":"11","author":"MJ Luitse","year":"2012","unstructured":"Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ (2012) Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 11:261\u2013271","journal-title":"Lancet Neurol"},{"key":"9311_CR52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 66:343\u2013348","journal-title":"Arch Neurol"},{"key":"9311_CR53","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.03.008","volume":"29","author":"LJ Launer","year":"2008","unstructured":"Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR (2008) AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 29:1587\u20131590","journal-title":"Neurobiol Aging"},{"key":"9311_CR54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/NEN.0b013e318288a8dd","volume":"72","author":"JJ Ramos-Rodriguez","year":"2013","unstructured":"Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL, Bacskai BJ, Garcia-Alloza M (2013) Rapid beta-amyloid deposition and cognitive impairment after cholinergic denervation in APP\/PS1 mice. J Neuropathol Exp Neurol 72:272\u2013285","journal-title":"J Neuropathol Exp Neurol"},{"key":"9311_CR55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresprot.2005.08.001","volume":"16","author":"E Dere","year":"2005","unstructured":"Dere E, Huston JP, De Souza Silva MA (2005) Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Res Brain Res Protoc 16:10\u201319","journal-title":"Brain Res Brain Res Protoc"},{"key":"9311_CR56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbr.2014.11.046","volume":"281","author":"KR Stover","year":"2015","unstructured":"Stover KR, Campbell MA, Van Winssen CM, Brown RE (2015) Analysis of motor function in 6-month-old male and female 3xTg-AD mice. Behav Brain Res 281:16\u201323","journal-title":"Behav Brain Res"},{"key":"9311_CR57","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9311-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9311-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:16:21Z","timestamp":1553642181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9311-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["9311"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9311-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}